HIV heterosexual transmission: a hypothesis about an additional potential determinant.

Transmission rates of human immunodeficiency virus (HIV) during heterosexual intercourse vary dramatically around the world. In Asia and South America, they are extraordinarily high, whereas in the United States and Europe, rates are much lower even after a large number of unprotected contacts. The transmission rates in Africa also probably are high, but the available studies unfortunately are weak. In Thailand, female-to-male transmission rates per contact were estimated at.056 (l in 18) compared to.0002 to.0015 (1/5000-1. 5/1000) for male-to-female transmission in the United States and Europe. Male-to-female transmission in Thailand appears to show, as expected, even greater transmission likelihood compared to female-to-male rates. In general, in the United States and Europe, transmission rates within heterosexual couples range from less than 10% to 22%, whereas in Thailand and Brazil, the rates exceed 40%. The much lower transmission rate per contact in the United States and Europe is based on an assumption that HIV transmitters are a homogeneous group. Wiley and colleagues argue that transmitters are likely to be a heterogeneous group with a large percentage of very low frequency transmitters and a small percentage of high frequency transmitters. That hypothesis is given some support by a cluster of cases in rural New York State in which one man appeared to infect 31% of his many contacts.

[1]  I. M. Belyakov,et al.  The importance of local mucosal HIV-specific CD8(+) cytotoxic T lymphocytes for resistance to mucosal viral transmission in mice and enhancement of resistance by local administration of IL-12. , 1998, The Journal of clinical investigation.

[2]  I. de Vincenzi,et al.  Probability of heterosexual transmission of HIV: relationship to the number of unprotected sexual contacts. European Study Group in Heterosexual Transmission of HIV. , 1996, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

[3]  E. Fenyö,et al.  Correlation between seroreactivity to HIV-1 V3 loop peptides and male-to-female heterosexual transmission. , 1993, AIDS.

[4]  M. Cloyd,et al.  Polymorphic human gene(s) determines differential susceptibility of CD4 lymphocytes to infection by certain HIV-1 isolates. , 1991, Virology.

[5]  A. Saah,et al.  Effects of micronutrient intake on survival in human immunodeficiency virus type 1 infection. , 1996, American journal of epidemiology.

[6]  J. Skurnick,et al.  CD3+CD8+ cell levels as predictors of transmission in human immunodeficiency virus-infected couples: a report from the heterosexual HIV transmission study. , 1998, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

[7]  S. Arya,et al.  Identification of RANTES, MIP-1α, and MIP-1β as the Major HIV-Suppressive Factors Produced by CD8+ T Cells , 1995, Science.

[8]  M. Baum,et al.  Micronutrient status in relationship to mortality in HIV-1 disease. , 2009, Nutrition reviews.

[9]  T. Delea,et al.  The Causal Role for Genital Ulcer Disease as a Risk Factor for Transmission of Human Immunodeficiency Virus: An Application of the Bradford Hill Criteria , 1996, Sexually transmitted diseases.

[10]  J. Wiley,et al.  Heterogeneity in the probability of HIV transmission per sexual contact: the case of male-to-female transmission in penile-vaginal intercourse. , 1989, Statistics in medicine.

[11]  W. Fawzi,et al.  A randomized trial of vitamin A supplements in relation to mortality among human immunodeficiency virus-infected and uninfected children in Tanzania. , 1999, The Pediatric infectious disease journal.

[12]  S. Rowland-Jones,et al.  Immune responses in HIV-exposed seronegatives: have they repelled the virus? , 1995, Current opinion in immunology.

[13]  R. Watson,et al.  Vitamins and immunomodulation in AIDS. , 1996, Nutrition.

[14]  D. Richman,et al.  A cross-sectional comparison of persons with syncytium- and non-syncytium-inducing human immunodeficiency virus. , 1993, The Journal of infectious diseases.

[15]  P. Piot,et al.  Cofactors in male-female sexual transmission of human immunodeficiency virus type 1. , 1991, The Journal of infectious diseases.

[16]  R. Chandra,et al.  Low serum vitamin B-12 concentrations are associated with faster human immunodeficiency virus type 1 (HIV-1) disease progression. , 1997, The Journal of nutrition.

[17]  C. Khamboonruang,et al.  Risk factors for HIV‐1 transmission from HIV‐seropositive male blood donors to their regular female partners in northern Thailand , 1997, AIDS.

[18]  S. Holmberg,et al.  Prior herpes simplex virus type 2 infection as a risk factor for HIV infection. , 1988, JAMA.

[19]  M. Robb,et al.  Epidemiologic and biologic characterization of a cohort of human immunodeficiency virus type 1 highly exposed, persistently seronegative female sex workers in northern Thailand. Chiang Mai HEPS Working Group. , 1999, The Journal of infectious diseases.

[20]  A. Baleta Concern voiced over “dry sex” practices in South Africa , 1998, The Lancet.

[21]  K. Tomecki Impact of improved treatment of sexually transmitted diseases on HIV infection in rural Tanzania: randomised controlled trial: Grosskurth J, Mosha F, Todd J, et al. Lancet 1995;346:530–536 , 1996 .

[22]  A. Lazzarin,et al.  Man-to-woman sexual transmission of HIV: longitudinal study of 343 steady partners of infected men. , 1993, Journal of acquired immune deficiency syndromes.

[23]  Aileen B. Sedman,et al.  A longitudinal study , 1987 .

[24]  S. O’Brien,et al.  C-C chemokines, pivotal in protection against HIV type 1 infection. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[25]  W. Willett,et al.  Dietary micronutrient intake and risk of progression to acquired immunodeficiency syndrome (AIDS) in human immunodeficiency virus type 1 (HIV-1)-infected homosexual men. , 1993, American journal of epidemiology.

[26]  E. Fenyö,et al.  Biological correlates of HIV‐1 heterosexual transmission , 1997, AIDS.

[27]  Ronald H Gray,et al.  Control of sexually transmitted diseases for AIDS prevention in Uganda: a randomised community trial , 1999, The Lancet.

[28]  J. Buring,et al.  Micronutrients and HIV‐1 disease progression , 1995, AIDS.

[29]  L. Kingsley,et al.  No association between herpes simplex virus type-2 seropositivity or anogenital lesions and HIV seroconversion among homosexual men. , 1990, Journal of acquired immune deficiency syndromes.

[30]  A. Muñoz,et al.  HIV infection among Female Partners of Seropositive Men in Brazil , 1995 .

[31]  J. Skurnick,et al.  HLA antigens associated with susceptibility/resistance to HIV-1 infection. , 1998, Human immunology.

[32]  C Khamboonruang,et al.  Changes in sexual behavior and a decline in HIV infection among young men in Thailand. , 1996, The New England journal of medicine.

[33]  G. Satten,et al.  Probability of female-to-male transmission of HIV-1 in Thailand , 1994, The Lancet.

[34]  A. De Rossi,et al.  HIV‐1 variability and progression to AIDS: A longitudinal study , 1990, Journal of medical virology.

[35]  E. Rosenberg,et al.  Vigorous HIV-1-specific CD4+ T cell responses associated with control of viremia. , 1997, Science.

[36]  J. Berzofsky,et al.  ENV-specific cytotoxic T lymphocyte responses in HIV seronegative health care workers occupationally exposed to HIV-contaminated body fluids. , 1995, The Journal of clinical investigation.

[37]  J. Albert,et al.  Transmission of human immunodeficiency virus type 1 (HIV-1) from mother to child correlates with viral phenotype. , 1993, Virology.

[38]  C. Giaquinto,et al.  DNA HLA-DRB1 analysis in children of positive mothers and estimated risk of vertical HIV transmission. , 1993, Disease markers.

[39]  Jw World Health Report 1995 , 1995 .

[40]  J. Skurnick,et al.  Status of selected nutrients and progression of human immunodeficiency virus type 1 infection. , 2000, The American journal of clinical nutrition.

[41]  S. Rowland-Jones,et al.  HIV-specific cytotoxic T-cells in HIV-exposed but uninfected Gambian women , 1995, Nature Medicine.

[42]  A. Saah,et al.  Association between serum vitamin A and E levels and HIV‐1 disease progression , 1997, AIDS.

[43]  I. Keet,et al.  Prognostic Value of HIV-1 Syncytium-Inducing Phenotype for Rate of CD4+ Cell Depletion and Progression to AIDS , 1993, Annals of Internal Medicine.

[44]  J. Wasserheit,et al.  Epidemiological Synergy: Interrelationships between Human Immunodeficiency Virus Infection and Other Sexually Transmitted Diseases , 1992, Sexually transmitted diseases.

[45]  J. Lifson,et al.  Non-cytolytic CD8 T-cell anti-HIV responses in primary HIV-1 infection , 1994, The Lancet.

[46]  L. Kingsley,et al.  Heterosexual HIV-1 transmission and viral load in hemophilic patients. , 1998, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

[47]  R. Scorza,et al.  HLA‐associated susceptibility to HIV‐1 infection , 1992, Clinical and experimental immunology.

[48]  R J Hayes,et al.  The cofactor effect of genital ulcers on the per-exposure risk of HIV transmission in sub-Saharan Africa. , 1995, The Journal of tropical medicine and hygiene.

[49]  M. Clerici,et al.  HIV-specific mucosal and cellular immunity in HIV-seronegative partners of HIV-seropositive individuals , 1997, Nature Medicine.

[50]  M. Barreto,et al.  Effect of vitamin A supplementation on diarrhoea and acute lower-respiratory-tract infections in young children in Brazil , 1994, The Lancet.

[51]  J. Bogden,et al.  Micronutrient Status and Human Immunodeficiency Virus (HIV) Infection , 1990, Annals of the New York Academy of Sciences.

[52]  C. Cassel,et al.  Poverty and Ill Health: Physicians Can, and Should, Make a Difference , 1998, Annals of Internal Medicine.

[53]  P. Kunasol,et al.  Searching: Business Source Complete Choose Databases » , 2022 .

[54]  J. Skurnick,et al.  Micronutrient profiles in HIV-1-infected heterosexual adults. , 1996, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

[55]  J J Goedert,et al.  Genetic Restriction of HIV-1 Infection and Progression to AIDS by a Deletion Allele of the CKR5 Structural Gene , 1996, Science.

[56]  J. Goedert,et al.  HLA antigen frequencies in HIV-1 seropositive disease-free individuals and patients with AIDS. , 1988, Journal of acquired immune deficiency syndromes.

[57]  J. Ward,et al.  Heterosexual transmission of human immunodeficiency virus type 1 from transfusion recipients to their sex partners. , 1994, Journal of acquired immune deficiency syndromes.

[58]  K. V. Bailey,et al.  Use of body mass index of adults in assessing individual and community nutritional status. , 1995, Bulletin of the World Health Organization.

[59]  Increased virulence of coxsackievirus B3 in mice due to vitamin E or selenium deficiency. , 1997, The Journal of nutrition.

[60]  F. Valentine,et al.  Lymphocytes from some long-term seronegative heterosexual partners of HIV-infected individuals proliferate in response to HIV antigens. , 1992, AIDS research and human retroviruses.

[61]  J. Canner,et al.  Maternal vitamin A deficiency and mother-to-child transmission of HIV-1 , 1994, The Lancet.

[62]  M Subramanian,et al.  The World Health Report 1995: bridging the gaps. , 1995 .

[63]  Donna Spiegelman,et al.  Randomised trial of effects of vitamin supplements on pregnancy outcomes and T cell counts in HIV-1-infected women in Tanzania , 1998, The Lancet.

[64]  J. Margolick,et al.  Increased mortality associated with vitamin A deficiency during human immunodeficiency virus type 1 infection. , 1993, Archives of internal medicine.

[65]  L. Clemow,et al.  Human immunodeficiency virus infection in sexually active wives of infected hemophilic men. , 1988, The American journal of medicine.

[66]  M. Roederer,et al.  Glutathione deficiency is associated with impaired survival in HIV disease. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[67]  J. Skurnick,et al.  Lack of infection in HIV-exposed individuals is associated with a strong CD8(+) cell noncytotoxic anti-HIV response. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[68]  J. Berzofsky,et al.  Human immunodeficiency virus type 1 (HIV-1)-seronegative injection drug users at risk for HIV exposure have antibodies to HLA class I antigens and T cells specific for HIV envelope. , 1996, The Journal of infectious diseases.

[69]  C. Kleeberger,et al.  CCR5 promoter polymorphism and HIV-1 disease progression , 1998, The Lancet.

[70]  J. Albert,et al.  Biological phenotypes of HIV-1 in pathogenesis and transmission. , 1994, Antibiotics and Chemotherapy.

[71]  W. Ray,et al.  No association between calcium channel blocker use and confirmed bleeding peptic ulcer disease. , 1998, American journal of epidemiology.

[72]  J. Goedert,et al.  High risk of HIV-1 infection for first-born twins , 1991, The Lancet.

[73]  D B Louria,et al.  Herpes simplex type II and Mycoplasma genitalium as risk factors for heterosexual HIV transmission: report from the heterosexual HIV transmission study. , 1998, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

[74]  R. Crystal,et al.  SYSTEMIC GLUTATHIONE DEFICIENCY IN SYMPTOM-FREE HIV-SEROPOSITIVE INDIVIDUALS , 1989, The Lancet.

[75]  M. Beck,et al.  Rapid genomic evolution of a non-virulent Coxsackievirus B3 in selenium-deficient mice results in selection of identical virulent isolates , 1995, Nature Medicine.

[76]  I. de Vincenzi,et al.  A Longitudinal Study of Human Immunodeficiency Virus Transmission by Heterosexual Partners , 1994 .

[77]  J. Cruse,et al.  HLA disease association and protection in HIV infection among African Americans and Caucasians. , 1991, Pathobiology : journal of immunopathology, molecular and cellular biology.

[78]  E. Vittinghoff,et al.  Heterosexual transmission of human immunodeficiency virus (HIV) in northern California: results from a ten-year study. , 1997, American journal of epidemiology.

[79]  D. Stram,et al.  Role of viral load in heterosexual transmission of human immunodeficiency virus type 1 by blood transfusion recipients. Transfusion Safety Study Group. , 1997, American journal of epidemiology.

[80]  H. Morse,et al.  H-2-associated and background genes influence the development of a murine retrovirus-induced immunodeficiency syndrome. , 1990, Journal of immunology.

[81]  H. Lai,et al.  High risk of HIV-related mortality is associated with selenium deficiency. , 1997, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

[82]  M. King,et al.  Genetic risk factors for perinatally acquired HIV-1 infection. , 1992, Paediatric and perinatal epidemiology.

[83]  L. Isa,et al.  Blood zinc status and zinc treatment in human immunodeficiency virus-infected patients , 1992, International journal of clinical & laboratory research.

[84]  John P. Moore,et al.  HIV–1 neutralizing antibodies: How full is the bottle? , 1999, Nature Medicine.

[85]  R. Osathanondh,et al.  HIV-1 Langerhans' Cell Tropism Associated with Heterosexual Transmission of HIV , 1996, Science.

[86]  A. Gringeri,et al.  Susceptibility to HIV infection and AIDS in Italian haemophiliacs is HLA associated , 1990, British journal of haematology.

[87]  P. Simmonds,et al.  HLA HAPLOTYPE A1 B8 DR3 AS A RISK FACTOR FOR HIV-RELATED DISEASE , 1988, The Lancet.

[88]  J. Todd,et al.  Impact of improved treatment of sexually transmitted diseases on HIV infection in rural Tanzania: randomised controlled trial , 1995, The Lancet.